Are you or a loved one taking a biosimilar medication?
Sign up for our Introduction to Biosimilars email series and get a more in-depth look into these treatments.
Since 2015, biosimilar medicines have generated $36 billion in savings and have been used in more than 2.7 billion days of patient therapy with no meaningful differences in clinical outcomes.
PATIENT-FIRST MEDICINES
PATIENT-FIRST MEDICINES
Biosimilars, while beneficial to the entire health care system, are for patients first.
JENI'S STORY
HELEN'S STORY
RESOURCES
ACCESSIBLE RESOURCES
Biosimilars increase access to needed treatments. Learn more from these resources.
DELIVERING SAVINGS
SAFE & EFFECTIVE MEDCINES
Often more affordable than reference biologics, FDA-approved biosimilars give millions of people access to these cutting-edge therapies.
